GI
WVE icon

GAMMA Investing’s Wave Life Sciences WVE Stock Holding History

GAMMA Investing’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.17K Buy
857
+381
+80% +$2K ﹤0.01% 3817
2026
Q2 		$2.77K Sell
476
-156
-25% -$1.03K ﹤0.01% 3667
2026
Q1 		$4.58K Sell
632
-60
-9% -$782 ﹤0.01% 3391
2025
Q4 		$11.8K Buy
692
+251
+57% +$2.55K ﹤0.01% 2904
2025
Q3 		$3.23K Sell
441
-75
-15% -$607 ﹤0.01% 3322
2025
Q2 		$3.35K Buy
516
+151
+41% +$997 ﹤0.01% 3257
2025
Q1 		$2.95K Buy
365
+61
+20% +$667 ﹤0.01% 3282
2024
Q4 		$3.76K Buy
304
+160
+111% +$2.14K ﹤0.01% 3024
2024
Q3 		$1.18K Buy
144
+110
+324% +$658 ﹤0.01% 3212
2024
Q2 		$170 Sell
34
-28
-45% -$160 ﹤0.01% 3371
2024
Q1 		$383 Buy
+62
New +$310 ﹤0.01% 3143

Other funds holding WVE

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GAMMA Investing's WVE Position: Q3 2026 in Review

GAMMA Investing increased its Wave Life Sciences (WVE) stake by 80% in Q3 2026, buying an estimated $2K and bringing the position to 857 shares worth $3.17K. The position accounts for ﹤0.01% of the portfolio, ranked #3817.

GAMMA Investing first reported a position in WVE in Q1 2024 and has held it in 11 quarters since. The position peaked at $11.8K in Q4 2025. 4 funds tracked by Wall St. Rank hold WVE as of Q3 2026.

  • GAMMA Investing held 857 shares of Wave Life Sciences worth $3.17K as of Q3 2026.
  • GAMMA Investing bought 381 Wave Life Sciences shares in Q3 2026, an estimated $2K.
  • Wave Life Sciences made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3817 holding.
  • GAMMA Investing first reported a position in Wave Life Sciences in Q1 2024 and has held it in 11 quarters since.
  • GAMMA Investing's Wave Life Sciences position peaked at $11.8K in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.